Tibor Szarvas

Budapest, BU, Hungary

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 173 publications

Comparative effectiveness of apalutamide-, abiraterone-, and enzalutamide-based doublets in mHSPC.

Comparative effectiveness of apalutamide-, abiraterone-, and enzalutamide-based doublets in mHSPC.

Journal: BJU international

Published: September 01, 2026

UCA1 copy number gain in serum cfDNA predicts next-generation antiandrogen resistance in metastatic castration-resistant prostate cancer.

UCA1 copy number gain in serum cfDNA predicts next-generation antiandrogen resistance in metastatic castration-resistant prostate cancer.

Journal: Scientific reports

Published: February 11, 2026

Efficacy and Safety Differences Between Abiraterone and Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-analysis of Real-World Studies.

Efficacy and Safety Differences Between Abiraterone and Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-analysis of Real-World Studies.

Journal: Targeted oncology

Published: January 29, 2026

Molecular subtype concordance and metastatic patterns in muscle-invasive bladder cancer.

Molecular subtype concordance and metastatic patterns in muscle-invasive bladder cancer.

Journal: The journal of pathology. Clinical research

Published: January 08, 2026

Prognostic and predictive factors of immune checkpoint inhibitor therapy in urinary bladder cancer.

Prognostic and predictive factors of immune checkpoint inhibitor therapy in urinary bladder cancer.

Journal: Pathology oncology research : POR

Published: December 17, 2025

Genetic characteristics and targeted treatments of primary bladder and urachal adenocarcinomas: a systematic review with pooled descriptive genomic analyses.

Genetic characteristics and targeted treatments of primary bladder and urachal adenocarcinomas: a systematic review with pooled descriptive genomic analyses.

Journal: Cancer metastasis reviews

Published: December 10, 2025

Correction: Comparative proteome and serum analysis identified FSCN1 as a marker of abiraterone resistance in castration-resistant prostate cancer.

Correction: Comparative proteome and serum analysis identified FSCN1 as a marker of abiraterone resistance in castration-resistant prostate cancer.

Journal: Prostate cancer and prostatic diseases

Published: December 09, 2025

Urachal cancer: a clinical, diagnostic, and therapeutic update.

Urachal cancer: a clinical, diagnostic, and therapeutic update.

Journal: Current opinion in urology

Published: November 30, 2025

Clinical and Molecular Predictors of Response and Survival in Patients with Urothelial Carcinoma Treated with Enfortumab Vedotin: A Systematic Review and Meta-analysis.

Clinical and Molecular Predictors of Response and Survival in Patients with Urothelial Carcinoma Treated with Enfortumab Vedotin: A Systematic Review and Meta-analysis.

Journal: European urology open science

Published: October 18, 2025

Prospective randomized analysis of operating time and safety of laparoscopic pyeloplasty with or without TriSect rapide® in adult patients with ureteropelvic junction obstruction.

Prospective randomized analysis of operating time and safety of laparoscopic pyeloplasty with or without TriSect rapide® in adult patients with ureteropelvic junction obstruction.

Journal: BMC urology

Published: July 29, 2025

Lymphovascular Invasion is Predictive for Adjuvant Platinum Therapy Benefit in Urothelial Bladder Cancer.

Lymphovascular Invasion is Predictive for Adjuvant Platinum Therapy Benefit in Urothelial Bladder Cancer.

Journal: Clinical genitourinary cancer

Published: July 04, 2025

Combining molecular patterns and clinical data for better immune checkpoint inhibitor prediction in metastatic urothelial carcinoma.

Combining molecular patterns and clinical data for better immune checkpoint inhibitor prediction in metastatic urothelial carcinoma.

Journal: Cancer immunology, immunotherapy : CII

Published: June 16, 2025

Showing 1-12 of 173

Last Updated: 09/26/2026